Abbott second-generation total bilirubin assay set - Taiwan Registration 8593a6d9031f55d294c359e6bf24983b
Access comprehensive regulatory information for Abbott second-generation total bilirubin assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8593a6d9031f55d294c359e6bf24983b and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used to quantify total bilirubin in human serum or plasma in adults and newborns on the Alinity c System.
A Clinical chemistry and clinical toxicology
A.1110 Bilirubin (total or direct) test system
Input;; QMS/QSD
Dates and Status
Sep 21, 2022
Sep 21, 2027

